These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 22698819)

  • 1. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
    Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D
    Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
    Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
    J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.
    Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ
    Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.
    Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
    Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
    J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [(η(6)-p-cymene)Ru(H2O)3](2+) binding capability of aminohydroxamates - A solution and solid state study.
    Parajdi-Losonczi PL; Bényei AC; Kováts É; Timári I; Muchova TR; Novohradsky V; Kasparkova J; Buglyó P
    J Inorg Biochem; 2016 Jul; 160():236-45. PubMed ID: 26971623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution equilibria of anticancer ruthenium(II)-(η(6)-p-cymene)-hydroxy(thio)pyr(id)one complexes: impact of sulfur vs. oxygen donor systems on the speciation and bioactivity.
    Enyedy EA; Sija E; Jakusch T; Hartinger CG; Kandioller W; Keppler BK; Kiss T
    J Inorg Biochem; 2013 Oct; 127():161-8. PubMed ID: 23721887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer activity and DNA binding of a bifunctional Ru(II) arene aqua-complex with the 2,4-diamino-6-(2-pyridyl)-1,3,5-triazine ligand.
    Busto N; Valladolid J; Martínez-Alonso M; Lozano HJ; Jalón FA; Manzano BR; Rodríguez AM; Carrión MC; Biver T; Leal JM; Espino G; García B
    Inorg Chem; 2013 Sep; 52(17):9962-74. PubMed ID: 23957818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
    Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
    Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.
    Caruso F; Pettinari R; Rossi M; Monti E; Gariboldi MB; Marchetti F; Pettinari C; Caruso A; Ramani MV; Subbaraju GV
    J Inorg Biochem; 2016 Sep; 162():44-51. PubMed ID: 27293144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro anticancer activity of ruthenium-cymene complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Savić A; Dulović M; Poljarević JM; Misirlić-Denčić S; Jovanović M; Bogdanović A; Trajković V; Sabo TJ; Grgurić-Šipka S; Marković I
    ChemMedChem; 2011 Oct; 6(10):1884-91. PubMed ID: 21805645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new promising application for highly cytotoxic metal compounds: η6-areneruthenium(II) phosphite complexes for the treatment of alveolar echinococcosis.
    Küster T; Lense N; Barna F; Hemphill A; Kindermann MK; Heinicke JW; Vock CA
    J Med Chem; 2012 May; 55(9):4178-88. PubMed ID: 22489925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the (pseudo)halido ligand in ruthenium(II)
    Biancalana L; Zanda E; Hadiji M; Zacchini S; Pratesi A; Pampaloni G; Dyson PJ; Marchetti F
    Dalton Trans; 2021 Nov; 50(43):15760-15777. PubMed ID: 34704998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, reactivity studies, structural aspects, and solution behavior of half sandwich ruthenium(II) N,N',N''-triarylguanidinate complexes.
    Singh T; Kishan R; Nethaji M; Thirupathi N
    Inorg Chem; 2012 Jan; 51(1):157-69. PubMed ID: 22148465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
    Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
    J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmium(II)--versus ruthenium(II)--arene carbohydrate-based anticancer compounds: similarities and differences.
    Hanif M; Nazarov AA; Hartinger CG; Kandioller W; Jakupec MA; Arion VB; Dyson PJ; Keppler BK
    Dalton Trans; 2010 Aug; 39(31):7345-52. PubMed ID: 20601976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diastereomerically pure platinum(II) complexes as antitumoral agents.: The influence of the mode of binding {(N), (N,O)- or (C,N)}- of (1S,2R)[(η5-C5H5)Fe{(η5-C5H4)CHNCH(Me)CH(OH)C6H5}] and the arrangement of the auxiliary ligands.
    Talancón D; López C; Font-Bardía M; Calvet T; Quirante J; Calvis C; Messeguer R; Cortés R; Cascante M; Baldomà L; Badia J
    J Inorg Biochem; 2013 Jan; 118():1-12. PubMed ID: 23123334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.